146 related articles for article (PubMed ID: 11228362)
1. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field.
Mars MH; de Jong MC; Franken P; van Oirschot JT
Vaccine; 2001 Feb; 19(15-16):1924-30. PubMed ID: 11228362
[TBL] [Abstract][Full Text] [Related]
2. A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments.
Mars MH; de Jong MC; van Oirschot JT
Vaccine; 2000 Apr; 18(19):1975-81. PubMed ID: 10706958
[TBL] [Abstract][Full Text] [Related]
3. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field.
Bosch JC; De Jong MC; Franken P; Frankena K; Hage JJ; Kaashoek MJ; Maris-Veldhuis MA; Noordhuizen JP; Van der Poel WH; Verhoeff J; Weerdmeester K; Zimmer GM; Van Oirschot JT
Vaccine; 1998; 16(2-3):265-71. PubMed ID: 9607041
[TBL] [Abstract][Full Text] [Related]
4. [Spread of an intramuscularly administered live gE-negative BHV1 marker vaccine in 2 cattle farms].
van der Poel WH; Hage JJ
Tijdschr Diergeneeskd; 1998 Feb; 123(4):109-11. PubMed ID: 9537086
[TBL] [Abstract][Full Text] [Related]
5. An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle.
Van Oirschot JT; Kaashoek MJ; Maris-Veldhuis MA; Weerdmeester K; Rijsewijk FA
J Virol Methods; 1997 Aug; 67(1):23-34. PubMed ID: 9274815
[TBL] [Abstract][Full Text] [Related]
6. A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations.
Mars MH; de Jong MC; van Oirschot JT
Vaccine; 2000 Apr; 18(20):2120-4. PubMed ID: 10715526
[TBL] [Abstract][Full Text] [Related]
7. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV.
Schrijver RS; Langedijk JP; Keil GM; Middel WG; Maris-Veldhuis M; Van Oirschot JT; Rijsewijk FA
Vaccine; 1997 Dec; 15(17-18):1908-16. PubMed ID: 9413101
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of latent bovine herpesvirus 1 in cattle seronegative to glycoproteins gB and gE.
Hage JJ; Glas RD; Westra HH; Maris-Veldhuis MA; Van Oirschot JT; Rijsewijk FA
Vet Microbiol; 1998 Feb; 60(2-4):87-98. PubMed ID: 9646441
[TBL] [Abstract][Full Text] [Related]
9. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
[TBL] [Abstract][Full Text] [Related]
10. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
[TBL] [Abstract][Full Text] [Related]
11. Transmission of bovine herpesvirus 1 within and between herds on an island with a BHV1 control programme.
Hage JJ; Schukken YH; Schols H; Maris-Veldhuis MA; Rijsewijk FA; Klaassen CH
Epidemiol Infect; 2003 Jun; 130(3):541-52. PubMed ID: 12825740
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal antibodies directed against the bovine herpesvirus-1 glycoprotein E and use for the differentiation between vaccinated and infected animals.
Letellier C; Delangre A; De Smet A; Kerkhofs P
Vet Microbiol; 2001 Dec; 83(4):301-15. PubMed ID: 11600264
[TBL] [Abstract][Full Text] [Related]
13. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
15. [Identification of an introduced bovine herpesvirus type 1 strain in a closed dairy herd by experimental virus reactivation followed by DNA restriction enzyme analysis].
van der Poel WH; Rijsewijk FA; Meijer FA; Verhoeff J
Tijdschr Diergeneeskd; 2000 Dec; 125(23):714-7. PubMed ID: 11125609
[TBL] [Abstract][Full Text] [Related]
16. Detection of bovine herpesvirus 1 glycoprotein E antibodies in individual milk samples by enzyme-linked immunosorbent assays.
Wellenberg GJ; Verstraten ER; Mars MH; Van Oirschot JT
J Clin Microbiol; 1998 Feb; 36(2):409-13. PubMed ID: 9466750
[TBL] [Abstract][Full Text] [Related]
17. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine.
Kaashoek MJ; van Oirschot JT
Vet Microbiol; 1996 Nov; 53(1-2):191-7. PubMed ID: 9011011
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against bovine herpesvirus (BHV) 5 may be differentiated from antibodies against BHV1 in a BHV1 glycoprotein E blocking ELISA.
Wellenberg GJ; Mars MH; Van Oirschot JT
Vet Microbiol; 2001 Jan; 78(1):79-84. PubMed ID: 11118743
[TBL] [Abstract][Full Text] [Related]
19. Strains of bovine herpesvirus 1 that do not express an epitope on glycoprotein E in cell culture still induce antibodies that can be detected in a gE-blocking ELISA.
van Oirschot JT; Kaashoek MJ; Maris-Veldhuis MA; Rijsewijk FA
Vet Microbiol; 1999 Mar; 65(2):103-13. PubMed ID: 10078594
[TBL] [Abstract][Full Text] [Related]
20. The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1.
Denis M; Hanon E; Rijsewijk FA; Kaashoek MJ; van Oirschot JT; Thiry E; Pastoret PP
Vet Microbiol; 1996 Nov; 53(1-2):121-32. PubMed ID: 9011004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
